Ausgabe 8/2012
Inhalt (19 Artikel)
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
Claudia A. Dumitru, Katrin Moses, Sokratis Trellakis, Stephan Lang, Sven Brandau
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy
Tonia Mazzarella, Valeria Cambiaghi, Nathalie Rizzo, Lorenzo Pilla, Danilo Parolini, Elena Orsenigo, Annalisa Colucci, Giulio Modorati, Claudio Doglioni, Giorgio Parmiani, Cristina Maccalli
FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer
Paul Salama, Colin Stewart, Cynthia Forrest, Cameron Platell, Barry Iacopetta
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors
Sofia Eberstål, Wiaam Badn, Sara Fritzell, Magnus Esbjörnsson, Anna Darabi, Edward Visse, Peter Siesjö
Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding
Leticia Huergo-Zapico, Ana P. Gonzalez-Rodriguez, Juan Contesti, Esther Gonzalez, Alejandro López-Soto, Azahara Fernandez-Guizan, Andrea Acebes-Huerta, Juan R. de los Toyos, Carlos Lopez-Larrea, Veronika Groh, Thomas Spies, Segundo Gonzalez
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy
Hiroki Yoshioka, Shinji Yamamoto, Hirofumi Hanaoka, Yasuhiko Iida, Pramila Paudyal, Tetsuya Higuchi, Hideyuki Tominaga, Noboru Oriuchi, Hidewaki Nakagawa, Yasuhiro Shiba, Koji Yoshida, Ryuji Osawa, Toyomasa Katagiri, Takuya Tsunoda, Yusuke Nakamura, Keigo Endo
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion
Marie Klinge Brimnes, Anne Ortved Gang, Marco Donia, Per thor Straten, Inge Marie Svane, Sine Reker Hadrup
Rituximab-induced direct inhibition of T-cell activation
Dina Stroopinsky, Tamar Katz, Jacob M. Rowe, Doron Melamed, Irit Avivi
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer
Emilia Andersson, Lisa Villabona, Kjell Bergfeldt, Joseph W. Carlson, Soldano Ferrone, Rolf Kiessling, Barbara Seliger, Giuseppe V. Masucci
Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways
Ming Li, Deborah A. Knight, Mark J. Smyth, Trina J. Stewart
CAR T cells transform to trucks: chimeric antigen receptor–redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer
Markus Chmielewski, Hinrich Abken
Harnessing human plasmacytoid dendritic cells as professional APCs
Jurjen Tel, Anne M. van der Leun, Carl G. Figdor, Ruurd Torensma, I. Jolanda M. de Vries
The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
Mads Hald Andersen
Re-purposing cancer therapeutics for breast cancer immunotherapy
Leisha A. Emens
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers
Kelly Barrios, Esteban Celis
Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)
Suzanne Ostrand-Rosenberg, Pratima Sinha, Olesya Chornoguz, Christopher Ecker
The expression, function, and clinical relevance of B7 family members in cancer
Barbara Seliger, Dagmar Quandt
Innate immune sensing of cancer: clues from an identified role for type I IFNs
Thomas F. Gajewski, Mercedes B. Fuertes, Seng-Ryong Woo
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10–13 October 2011, Copenhagen, Denmark
Tania Køllgaard, Joost H. van den Berg, Marco Donia, Per thor Straten